• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多囊卵巢综合征女性的血脂异常:发生率、模式和预测因素。

Dyslipidemia in women with polycystic ovary syndrome: incidence, pattern and predictors.

机构信息

Serviço de Endocrinologia e Metabologia, Hospital das Clínicas da Faculdade de Medicina da Universidade, São Paulo, SP, Brazil.

出版信息

Gynecol Endocrinol. 2011 Oct;27(10):814-9. doi: 10.3109/09513590.2010.508852. Epub 2010 Sep 1.

DOI:10.3109/09513590.2010.508852
PMID:20807166
Abstract

One hundred forty-two women with polycystic ovary syndrome (PCOS) with an average body mass index (BMI) of 29.1 kg/m(2) and average age of 25.12 years were studied. By BMI, 30.2% were normal, 38.0% were overweight and 31.6% were obese. Thirty-one eumenorrheic women matched for BMI and age, with no evidence of hyperandrogenism, were recruited as controls. The incidence of dyslipidemia in the PCOS group was twice that of the Control group (76.1% versus 32.25%). The most frequent abnormalities were low high-density lipoprotein cholesterol (HDL-C; 57.6%) and high triglyceride (TG) (28.3%). HDL-C was significantly lower in all subgroups of women with PCOS when compared to the subgroups of normal women. No significant differences were seen in the total cholesterol (p = 0.307), low-density lipoprotein cholesterol (LDL-C; p = 0.283) and TGs (p = 0.113) levels among the subgroups. An independent effect on HDL-C was detected for glucose (p = 0.004) and fasting insulin (p = 0.01); on TG for age (p = 0.003) and homeostatic model assessment insulin resistance (p = 0.03) and on total cholesterol and LDL-C for age (p = 0.02 and p = 0.033, respectively). In conclusion, dyslipidemia is common in women with PCOS, mainly due to low HDL-C levels. BMI has a significant impact on this abnormality.

摘要

本研究纳入了 142 名多囊卵巢综合征(PCOS)女性患者,平均 BMI 为 29.1kg/m²,平均年龄为 25.12 岁。根据 BMI,30.2%的患者为正常体重,38.0%为超重,31.6%为肥胖。同期纳入了 31 名年龄和 BMI 匹配、无高雄激素血症证据的月经正常女性作为对照组。与对照组(32.25%)相比,PCOS 组的血脂异常发生率为对照组的两倍(76.1%)。最常见的异常是低高密度脂蛋白胆固醇(HDL-C;57.6%)和高三酰甘油(TG)(28.3%)。与正常女性亚组相比,所有 PCOS 女性亚组的 HDL-C 均显著降低。各组间总胆固醇(p = 0.307)、低密度脂蛋白胆固醇(LDL-C;p = 0.283)和 TG(p = 0.113)水平无显著差异。葡萄糖(p = 0.004)和空腹胰岛素(p = 0.01)对 HDL-C 有独立影响;年龄对 TG(p = 0.003)和稳态模型评估胰岛素抵抗(HOMA-IR;p = 0.03)有独立影响,年龄对总胆固醇和 LDL-C 有独立影响(p = 0.02 和 p = 0.033)。综上所述,血脂异常在 PCOS 女性中很常见,主要是由于 HDL-C 水平降低。BMI 对这种异常有显著影响。

相似文献

1
Dyslipidemia in women with polycystic ovary syndrome: incidence, pattern and predictors.多囊卵巢综合征女性的血脂异常:发生率、模式和预测因素。
Gynecol Endocrinol. 2011 Oct;27(10):814-9. doi: 10.3109/09513590.2010.508852. Epub 2010 Sep 1.
2
Metabolic syndrome in adolescents with polycystic ovary syndrome.青少年多囊卵巢综合征患者的代谢综合征。
Gynecol Endocrinol. 2011 Oct;27(10):820-2. doi: 10.3109/09513590.2010.508851. Epub 2010 Sep 1.
3
Is subclinical hypothyroidism contributing dyslipidemia and insulin resistance in women with polycystic ovary syndrome?亚临床甲状腺功能减退症是否导致多囊卵巢综合征妇女的血脂异常和胰岛素抵抗?
Gynecol Endocrinol. 2012 Aug;28(8):615-8. doi: 10.3109/09513590.2011.650765. Epub 2012 Feb 14.
4
Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype.排卵型与无排卵型多囊卵巢综合征表型中动脉粥样硬化性血脂异常的较轻形式
Hum Reprod. 2009 Sep;24(9):2286-92. doi: 10.1093/humrep/dep121. Epub 2009 May 19.
5
Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.载脂蛋白 A-I 和 B 水平、血脂异常和代谢综合征与中国西南部多囊卵巢综合征妇女。
Hum Reprod. 2012 Aug;27(8):2484-93. doi: 10.1093/humrep/des191. Epub 2012 Jun 6.
6
Relation between C-reactive protein and body mass index in patients with polycystic ovarian syndrome.多囊卵巢综合征患者 C 反应蛋白与体重指数的关系。
Gynecol Endocrinol. 2011 Jul;27(7):480-5. doi: 10.3109/09513590.2010.501876. Epub 2010 Sep 14.
7
Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.非肥胖和肥胖多囊卵巢综合征患者的脂蛋白和同型半胱氨酸水平。
Gynecol Endocrinol. 2005 May;20(5):258-63. doi: 10.1080/09513590400027265.
8
Hypoadiponectinemia: a useful marker of dyslipidemia in women with polycystic ovary syndrome.低脂联素血症:多囊卵巢综合征女性血脂异常的有用标志物。
Taiwan J Obstet Gynecol. 2012 Dec;51(4):583-90. doi: 10.1016/j.tjog.2012.09.014.
9
Lipid and lipoprotein profile in women with polycystic ovary syndrome.多囊卵巢综合征女性的脂质和脂蛋白谱
Can J Physiol Pharmacol. 2008 Apr;86(4):199-204. doi: 10.1139/Y08-014.
10
Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations.吡格列酮治疗不同临床表现的非肥胖育龄期多囊卵巢综合征女性。
Gynecol Endocrinol. 2007;23(8):461-7. doi: 10.1080/09513590701492689.

引用本文的文献

1
Tenascin-C levels in polycystic ovary syndrome and polycystic ovarian morphology.多囊卵巢综合征和多囊卵巢形态中的腱生蛋白-C水平
North Clin Istanb. 2025 Jun 11;12(3):344-351. doi: 10.14744/nci.2024.03295. eCollection 2025.
2
Correlation between Serum Caspase-1, IL-10, HOMA-IR, FAI, Dyslipidemia, and Oxidative Stress Status in Women with Polycystic Ovary Syndrome.多囊卵巢综合征女性血清半胱天冬酶-1、白细胞介素-10、胰岛素抵抗指数、游离雄激素指数、血脂异常与氧化应激状态之间的相关性
J Pharm Bioallied Sci. 2025 May;17(Suppl 1):S369-S371. doi: 10.4103/jpbs.jpbs_1994_24. Epub 2025 Feb 21.
3
Relationship Between Lipid Profile and Body Mass Index in Patients With Polycystic Ovarian Syndrome: A Cross-Sectional Study Among Indian Women of Reproductive Age.
多囊卵巢综合征患者血脂谱与体重指数的关系:一项针对印度育龄女性的横断面研究。
Cureus. 2024 Jun 26;16(6):e63251. doi: 10.7759/cureus.63251. eCollection 2024 Jun.
4
High levels of fatty acid-binding protein 5 excessively enhances fatty acid synthesis and proliferation of granulosa cells in polycystic ovary syndrome.多囊卵巢综合征中,脂肪酸结合蛋白5的高表达过度增强了颗粒细胞的脂肪酸合成和增殖。
J Ovarian Res. 2024 Feb 19;17(1):44. doi: 10.1186/s13048-024-01368-6.
5
Alleviation of Limosilactobacillus reuteri in polycystic ovary syndrome protects against circadian dysrhythmia-induced dyslipidemia via capric acid and GALR1 signaling.罗伊氏乳杆菌缓解多囊卵巢综合征通过癸酸和 GALR1 信号通路预防昼夜节律紊乱诱导的血脂异常。
NPJ Biofilms Microbiomes. 2023 Jul 8;9(1):47. doi: 10.1038/s41522-023-00415-2.
6
Association analysis of LHCGR variants and polycystic ovary syndrome in Punjab: a case-control approach.LHCGR 变异与旁遮普多囊卵巢综合征的关联分析:病例对照研究。
BMC Endocr Disord. 2022 Dec 30;22(1):335. doi: 10.1186/s12902-022-01251-9.
7
Impact of dyslipidemia on the cumulative pregnancy outcomes after first ovarian stimulation.脂质代谢异常对首次卵巢刺激后累积妊娠结局的影响。
Front Endocrinol (Lausanne). 2022 Aug 9;13:915424. doi: 10.3389/fendo.2022.915424. eCollection 2022.
8
Hirsutism, Normal Androgens and Diagnosis of PCOS.多毛症、雄激素正常与多囊卵巢综合征的诊断
Diagnostics (Basel). 2022 Aug 9;12(8):1922. doi: 10.3390/diagnostics12081922.
9
Prevalence, Pattern and Predictors for Dyslipidemia of Chinese Women With Polycystic Ovary Syndrome.中国多囊卵巢综合征女性血脂异常的患病率、模式及预测因素
Front Cardiovasc Med. 2021 Dec 15;8:790454. doi: 10.3389/fcvm.2021.790454. eCollection 2021.
10
Metabolic Features of Women With Polycystic Ovary Syndrome in Latin America: A Systematic Review.拉美多囊卵巢综合征女性的代谢特征:系统评价。
Front Endocrinol (Lausanne). 2021 Oct 19;12:759835. doi: 10.3389/fendo.2021.759835. eCollection 2021.